1, 5-diaminopentan-3-ol compounds and related treatment methods

Details 1, 5-diaminopentan-3-ol compounds and related treatment methods 1, 5-diaminopentan-3-ol compounds and related treatment methods

2004-06-14

2009-08-04

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S187000

Reexamination Certificate

active

07569585

ABSTRACT:
Substituted 1,5-diaminopentan-3-ol compounds and methods of making the same. Pharmaceutical compositions containing these compounds and methods of treatment using these pharmaceutical compositions.

REFERENCES:
patent: 2948722 (1960-08-01), Biel
patent: 4366172 (1982-12-01), Lednicer
patent: 4442103 (1984-04-01), Saari
patent: 4923865 (1990-05-01), Cossement et al.
patent: 5801201 (1998-09-01), Graudums et al.
patent: 6410790 (2002-06-01), Sundermann et al.
patent: 2003/0008859 (2003-01-01), Sundermann et al.
patent: E 28 628 (1979-04-01), None
patent: 28 39 891 (1979-04-01), None
patent: 195 47 766 (1997-06-01), None
patent: 692 21 919 (1997-10-01), None
patent: 199 15 601 (2000-10-01), None
patent: 199 63 175 (2001-07-01), None
patent: 0 112 669 (1987-07-01), None
patent: 0 506 478 (1997-09-01), None
patent: 783 627 (1957-09-01), None
Equi et al. “Oxidation of putrescine and . . . ” CA 114:164573 (1991).
King et al. “alpha sub 2 adrenergic . . . ” PASCAL No. 82-0146497 (1982).
Shouse et al. “The alpha sub 2 adrenoreceptor . . . ” PASCAL No. 96-0425050 (1996).
Spencer et al. :Ephedrine inhbits . . . BIOSIS No. 200510318615.
Barrett “Substituted pyrrocolines” CA52:40773 (1955).
Blick et al. “Disubstitution of cycloalkanones . . . ” CA 54:28385 (1959).
Radbruch et al. “A risk benefit . . . ” CA 125:157519 (1996).
Obata et al. “Evaluation and structure-activity . . . ” CA 134:335974 (2001).
Rojas et al. “Role of 5-HT1A . . . ” CA 142:367488 (2005).
Barrett et al. “Aminoalkyl tertiary . . . ” CA 52:65844 (1958).
Biel et al. “1-(1,2,3,4-tetrahydroisoquinolino . . . ” CA 55:13517 (1961).
Pascal et al. “New antihistaminic theophylline . . . ” CA 102:166527 (1985).
Salminen et al. “Three dimensional model . . . ” J. Biol. chem. v.274, p. 23405-23413 (1999).
Blicke et al.,Disubstitution of Cycloalkanones in the Mannich Reaction, J. Org. Chem., vol. 24, 1959, pp. 1069-1076.
International Search Report.

Affiliated with

Also associated with

Rating

1, 5-diaminopentan-3-ol compounds and related treatment methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1, 5-diaminopentan-3-ol compounds and related treatment methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1, 5-diaminopentan-3-ol compounds and related treatment methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4090503